KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Receivables - Other (2023 - 2025)

Historic Receivables - Other for TherapeuticsMD (TXMD) over the last 7 years, with Q3 2025 value amounting to $3.7 million.

  • TherapeuticsMD's Receivables - Other rose 1029.19% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 1029.19%. This contributed to the annual value of $19.6 million for FY2024, which is 927.97% down from last year.
  • As of Q3 2025, TherapeuticsMD's Receivables - Other stood at $3.7 million, which was up 1029.19% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Receivables - Other registered a high of $21.6 million during Q4 2023, and its lowest value of $2.9 million during Q2 2024.
  • Moreover, its 3-year median value for Receivables - Other was $3.4 million (2024), whereas its average is $5.6 million.
  • As far as peak fluctuations go, TherapeuticsMD's Receivables - Other plummeted by 8348.94% in 2024, and later surged by 2871.39% in 2025.
  • Over the past 3 years, TherapeuticsMD's Receivables - Other (Quarter) stood at $21.6 million in 2023, then plummeted by 83.49% to $3.6 million in 2024, then rose by 2.89% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.7 million for Q2 2025, and $3.0 million during Q1 2025.